Acceptability of offering financial incentives to achieve medication adherence in patients with severe mental illness: A focus group study

Journal of Medical Ethics

Volumn 36, Issue 8, 2010, Pages 463-468

  Priebe, Stefan ^a   Sinclair, Julia ^b   Burton, Alexandra ^a   Marougka, Stamatina ^a   Larsen, John ^c   Firn, Mike ^d   Ashcroft, Richard ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL SOUTH HANTS HOSPITAL   (United Kingdom)

^c Rethink   (United Kingdom)

^d SPRINGFIELD UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HUMAN; INFORMATION PROCESSING; MALE; MENTAL DISEASE; MIDDLE AGED; MOTIVATION; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; REWARD; UNITED KINGDOM;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; COST-BENEFIT ANALYSIS; FEMALE; FOCUS GROUPS; GREAT BRITAIN; HUMANS; MALE; MEDICATION ADHERENCE; MENTAL DISORDERS; MIDDLE AGED; MOTIVATION; REWARD; YOUNG ADULT;

EID: 77958113238     PISSN: 03066800     EISSN: 14734257     Source Type: Journal    
DOI: 10.1136/jme.2009.035071     Document Type: Article

References (16)

1. National Institute for Clinical Excellence. Schizophrenia. Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. London: NICE, 2002.
2. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions. Scientific review. JAMA 2002;288:2868-79.
3. O'Donnell C, Donohoe G, Sharkey L, et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ 2003;327:834.
4. Priebe S, Fakhoury W, Watts J, et al. Assertive Outreach Teams in London: models of Operation Pan-London Assertive Outreach study, Part 3. Br J Psychiatry 2003;183:148-54.
5. Appleby L. Safer services: conclusions from the report of the National Confidential Inquiry. Adv Psychiatr Treat 2000;6:5-15.
6. Bartlett P, Lewis O, Thorold O. Mental Disability and the European Convention on Human Rights. Leiden: Martinus Nijhoff 2007.
7. Giuffrida A, Togerson DJ. Should we pay the patient? Review of financial incentives to enhance patient compliance. BMJ 1997;315:703-7.
8. Burton A, Marougka SM, Priebe S. Do financial incentives increase treatment adherence in people with severe mental illness? A systematic review. Epidemiol Psichiatr Soc. In press.
9. Claassen D, Fakhoury WK, Ford R, et al. Money for medication: financial incentives to improve medication adherence in assertive outreach. Psychiatr Bull 2007;31:4-7.
10. Shaw J. Is it acceptable for people to be paid to adhere to medication? No. BMJ 2007;335:232-3.
11. Claassen D. Financial incentives for antipsychotic depot medication: ethical issues. J Med Ethics 2007;33:189-93.
12. Szmukler G. Financial incentives for patients in the treatment of psychosis. J Med Ethics 2009;35:224-8.
13. Burns T. Is it acceptable for people to be paid to adhere to medication? Yes. BMJ 2007;335:232-3.
14. Kass NE. An ethics framework for public health. Am J Public Health 2001;91:1776-82.
15. Beauchamp TL. Methods and principles in biomedical ethics. J Med Ethics 2003;29:269-74.
16. Banks S, Scully JL, Shakespeare T. Ordinary ethics: lay people's deliberations on sex selection. New Genet Soc 2006;25:289-303.